Details of the Drug Reposition

General Information of This Drug (ID: DM8MJ3F)

Drug Name
PB1046   DM8MJ3F
Synonyms Pemziviptadil; PB1046 Vasomera; PB-1120 Vasomera
Drug Type
Recombinant protein

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pulmonary arterial hypertension DISP8ZX5 BB01.0 Phase 2 [1]
Heart failure DISJW62S BD10-BD13 Phase 2 [2]
------------------------------------------------------------------------------------
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Duchenne dystrophy DISHFA7H 8C70 Phase 1 [2]
Hypertension DISLL965 BA00-BA04 Phase 1 [3]
Cardiomyopathy DISUPZRG BC43 Phase 1 [4]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03795428) Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 (VIP Extend). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of PhaseBio.
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)